Anavex Life Sciences Corp (AVXL)

[XenaLives]

Compiled:AVXL -The Stock and the Market 08/07/19
___________________________________________________________________________________________________
AMRN - AVXL stock comparison:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145046917

"Anavex in Five Years", perspective from falconer66a
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148898022

Will Anavex business model include a novel development in precision medicine?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148557900

Discussion on 4/25/19 concerning new blood tests for Alzheimer's - read forward from here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148425843

How the pros take out stops...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150305491

Anavex in stealth mode:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150311481

Evaluation of market cap potential of AVXL:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143725918

Interesting look at what was expected of AVXL in 11/14:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148475152

Retrospective look at Missling's appointment as CEO:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148475334

2015 interview of Missling stating that knowledge will be the goal of the 2a adaptive trial which will increase our chance of success:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148475720

Prediction that AVXL would reverse Alzheimer's from 2013:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148475575

Missling without quite so much hair here:
http://spotlightonbioadvances.homestead.com/Case-Study.html

How Missling is using the old FDA process to create new precision medicine processes:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148611726

Biostock's AI program estmates 89% chance of approval:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148688289

Little Orphan Anavex - a 2016 post...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=122025509

Historical short interest:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145900941

Hint at actual AVXL value:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147273799

F1ash statements on the Cantor ATM:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146081099

Charts showing periods of institutional accumulation:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=144037184

Gross market estimates from falconer66a:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145757480

Pharma growth predictions (from Talon38)
https://www.biospace.com/article/deloitte-predicts-pharma-growth-driven-by-orphan-disease-drugs-and-external-deals

MycrolftHolmes on Barriers to investment in AVXL:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=135326763

Short interest note from georgejjl:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147068381

Perspective on how quickly Anavex could morph into a profitable entity , making further dilution unnecessary. This may provide urgency for institutions to establish a position where stock has limited liquidity resulting in a pre-approval ramp up of pricing.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143560772